About FGPC
Pharmaceutical science, done here in the UAE
First Gulf Pharmaceuticals Centre is the first bioequivalence research centre in the Middle East, operating since 2012. We help manufacturers, researchers and healthcare providers move from the molecule to the market.
Who we are
From the first sample to the final report
FGPC brings together the work a pharmaceutical product needs before it reaches patients: bioequivalence and clinical research, bioanalysis by LC-MS/MS, formulation development, and registration with health authorities. Alongside it, we distribute medical, cosmetic and life-saving products and help develop hospitals and medical facilities.
Our laboratory serves pharmaceutical companies and the wider research community, including university researchers and food, water, agriculture and environmental organisations.
| Test | Specification | Result | |
|---|---|---|---|
| Assay (LC-MS/MS) | 95.0 – 105.0 % | 99.4 % | Complies |
| Related substances, total | ≤ 1.0 % | 0.32 % | Complies |
| Dissolution, 30 min | ≥ 80 % (Q) | 92 % | Complies |
| Water content | ≤ 2.0 % | 0.8 % | Complies |
The format of the certificate you receive. Figures are illustrative.
Founder & CEO message
Every discovery is a step toward better treatment
Dr. Mariam Al MansooriFounder & CEO · First Gulf Pharmaceuticals CentreWe believe that every scientific discovery is a step toward better treatment and a healthier life.
Dr. Mariam Al Mansoori founded First Gulf Pharmaceuticals Centre in 2012 to bring pharmaceutical research and regulatory expertise closer to the companies and researchers who need it in the UAE.
Our values
What you can hold us to
Every method validated, every sample logged, every result reviewed by a second analyst.
Every study and every analysis exists to bring safe, effective treatment to patients.
Studies and dossiers written for the regulator who will read them.
A non-disclosure agreement before any confidential file, formulation or sample.
A signed certificate of analysis or study report for every project.
One point of contact from the first enquiry to the final report.
How a project runs
Five steps, agreed in writing before we start
Tell us about the product or samples. We sign a non-disclosure agreement first if you need one.
We confirm the study design or the analytical method, the timeline and the price, in writing.
For clinical studies, ethics and regulatory approvals are in place before any volunteer is dosed.
Samples are logged, analysed with calibration standards and quality controls, and reviewed by a second analyst.
You receive a signed certificate of analysis or a final study report, ready for your dossier or publication.
Management
Managed by Netus Health
FGPC is managed by Netus Health, a UAE healthcare management company licensed in Abu Dhabi. Netus Health runs operations, quality and finance, so our scientists can focus on the science.
Floor 15, Office B, Jumeirah Emirates Towers, Dubai, United Arab Emirates
A new research and laboratory centre in Al Ain.
Tell us about your product or your samples
We reply with the right method, a timeline and a written quotation. A non-disclosure agreement comes first if you need one.